A spectacular effect of tocilizumab in Takayasu arteritis
Background: Anti-interleukin-6 receptors (anti-IL-6R) have been a promising new therapeutic alternative in the treatment of Takayasu arteritis. Case description: We report the case of a 34-year-old patient with Takayasu arteritis diagnosed in 2017. While she was on corticosteroid and methotrexate, t...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SMC MEDIA SRL
2024-11-01
|
| Series: | European Journal of Case Reports in Internal Medicine |
| Subjects: | |
| Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/4868 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850108185304629248 |
|---|---|
| author | Fatma Saïd Ines Naceur Tayssir Ben Achour Mayssam Jridi Monia Smiti |
| author_facet | Fatma Saïd Ines Naceur Tayssir Ben Achour Mayssam Jridi Monia Smiti |
| author_sort | Fatma Saïd |
| collection | DOAJ |
| description | Background: Anti-interleukin-6 receptors (anti-IL-6R) have been a promising new therapeutic alternative in the treatment of Takayasu arteritis.
Case description: We report the case of a 34-year-old patient with Takayasu arteritis diagnosed in 2017. While she was on corticosteroid and methotrexate, the patient presented twice with clinical and radiological signs of activity, requiring an increase of corticosteroid dose and an increase in the methotrexate dose to 20 mg/week. Anti-IL-6R infusions were indicated. At the end of the fifth infusion, the patient was totally asymptomatic: she no longer experienced episodes of syncope or amnesia.
Conclusion: Our case perfectly illustrates the effectiveness of anti-IL-6R in the treatment of Takayasu arteritis, especially in its refractory form. |
| format | Article |
| id | doaj-art-8fcdeb70b4534df7a28b76ff6e16bac9 |
| institution | OA Journals |
| issn | 2284-2594 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | SMC MEDIA SRL |
| record_format | Article |
| series | European Journal of Case Reports in Internal Medicine |
| spelling | doaj-art-8fcdeb70b4534df7a28b76ff6e16bac92025-08-20T02:38:26ZengSMC MEDIA SRLEuropean Journal of Case Reports in Internal Medicine2284-25942024-11-0110.12890/2024_0048684403A spectacular effect of tocilizumab in Takayasu arteritisFatma Saïd0Ines Naceur1Tayssir Ben Achour2Mayssam Jridi3Monia Smiti4Internal Medicine, University Hospital La Rabta, Tunis, Tunisia; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, TunisiaInternal Medicine, University Hospital La Rabta, Tunis, Tunisia; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, TunisiaInternal Medicine, University Hospital La Rabta, Tunis, Tunisia; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, TunisiaInternal Medicine, University Hospital La Rabta, Tunis, Tunisia; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, TunisiaInternal Medicine, University Hospital La Rabta, Tunis, Tunisia; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, TunisiaBackground: Anti-interleukin-6 receptors (anti-IL-6R) have been a promising new therapeutic alternative in the treatment of Takayasu arteritis. Case description: We report the case of a 34-year-old patient with Takayasu arteritis diagnosed in 2017. While she was on corticosteroid and methotrexate, the patient presented twice with clinical and radiological signs of activity, requiring an increase of corticosteroid dose and an increase in the methotrexate dose to 20 mg/week. Anti-IL-6R infusions were indicated. At the end of the fifth infusion, the patient was totally asymptomatic: she no longer experienced episodes of syncope or amnesia. Conclusion: Our case perfectly illustrates the effectiveness of anti-IL-6R in the treatment of Takayasu arteritis, especially in its refractory form.https://www.ejcrim.com/index.php/EJCRIM/article/view/4868takayasu arteritistocilizumabanti-il6 refractory form |
| spellingShingle | Fatma Saïd Ines Naceur Tayssir Ben Achour Mayssam Jridi Monia Smiti A spectacular effect of tocilizumab in Takayasu arteritis European Journal of Case Reports in Internal Medicine takayasu arteritis tocilizumab anti-il6 refractory form |
| title | A spectacular effect of tocilizumab in Takayasu arteritis |
| title_full | A spectacular effect of tocilizumab in Takayasu arteritis |
| title_fullStr | A spectacular effect of tocilizumab in Takayasu arteritis |
| title_full_unstemmed | A spectacular effect of tocilizumab in Takayasu arteritis |
| title_short | A spectacular effect of tocilizumab in Takayasu arteritis |
| title_sort | spectacular effect of tocilizumab in takayasu arteritis |
| topic | takayasu arteritis tocilizumab anti-il6 refractory form |
| url | https://www.ejcrim.com/index.php/EJCRIM/article/view/4868 |
| work_keys_str_mv | AT fatmasaid aspectaculareffectoftocilizumabintakayasuarteritis AT inesnaceur aspectaculareffectoftocilizumabintakayasuarteritis AT tayssirbenachour aspectaculareffectoftocilizumabintakayasuarteritis AT mayssamjridi aspectaculareffectoftocilizumabintakayasuarteritis AT moniasmiti aspectaculareffectoftocilizumabintakayasuarteritis AT fatmasaid spectaculareffectoftocilizumabintakayasuarteritis AT inesnaceur spectaculareffectoftocilizumabintakayasuarteritis AT tayssirbenachour spectaculareffectoftocilizumabintakayasuarteritis AT mayssamjridi spectaculareffectoftocilizumabintakayasuarteritis AT moniasmiti spectaculareffectoftocilizumabintakayasuarteritis |